SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Abbott India informs about Board Meeting

04 Jun 2013 Evaluate

Abbott India has informed that the Board of Directors of the Company at its meeting held on June 03, 2013, has decided to defer the proposal received by the Company for the sale and transfer of, or other appropriate restructuring of, the proprietary pharmaceuticals division of the Company.

The above information is a part of company’s filings submitted to BSE.

Abbott India Share Price

25578.90 -218.25 (-0.85%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×